Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds
Chen JS, Zhu H, Chai TQ, et al.
Biosensors, 2026;16(4)
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Mavrych V, Shypilova I, Bolgova O
Frontiers in aging, 2026;7:1790247
Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis
Jarso G, Mahendru S, Dutta A, et al.
Indian journal of endocrinology and metabolism, 2026;30(2):129-134
Spontaneous Pneumomediastinum Associated with Semaglutide Therapy: A Case Report
Diebold J, Gubler C, Murray FR
Case reports in gastroenterology, 2026;20(1):149-156
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Coutinho LFD, DE Oliveira Neves LF, Camilo RP
The Journal of sports medicine and physical fitness, 2026
GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes
Amorim Moreira Alves G, Teranishi M, Majumdar R, et al.
Chronic diseases and translational medicine, 2026;12(2):85-99
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management
Yuan C, Demers A, Silva-Ortiz V, et al.
International journal of molecular sciences, 2026;27(6)
Semaglutide in Metabolic Medicine: A Review on Clinical Applications and Emerging Therapeutics
Aljabri AA
Saudi medical journal, 2026;47(4):615-625
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats
Grubisic MM, Strbe S, Barisic I, et al.
Current neuropharmacology, 2026
Cytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics
Sikiric P, Barisic I, Udovicic M, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(3)
Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study
Smolderen KG, Mena-Hurtado C, Divino V, et al.
American journal of preventive cardiology, 2026;27:101521
Anti-Obesity Pharmacotherapy and Emerging Multimodal Interventions for Obstructive Sleep Apnea
Preshy A, Fernandez CJ, Nedai MH, et al.
Chronic diseases and translational medicine, 2026;12(2):100-112
Comparative Proteomic Analysis of the Secretome of Control and BRAF/MEK Inhibitor-Resistant Melanoma Cells
Simiczyjew A, Surman M, Kot M, et al.
Journal of proteome research, 2026;25(4):2084-2097
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review
Matek D, Matek I, Japjec M, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(2)
Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications
Lachowicz JI, Congiu T, Salis A, et al.
International journal of molecular sciences, 2026;27(4)
Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias
Sikiric P, Barisic I, Udovicic M, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(2)
Fourier Transform Infrared Spectroscopic Characterization of Aortic Wall Remodeling by Stable Gastric Pentadecapeptide BPC 157 After Unilateral Adrenalectomy in Rats
Smoday IM, Vukovic V, Oroz K, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(1)
Decidualization-empowered ECM hydrogel integrating sustained Tβ4 release drives endometrial regeneration in intrauterine adhesions
Liang Y, Yu Z, Du S, et al.
Nature communications, 2026;17(1)
Thymosin beta 4: An emerging therapeutic candidate for kidney diseases
Di H, Huang J, Zhang D, et al.
Peptides, 2026;195:171467
Tracheocutaneous Fistula Resolved by Pentadecapeptide BPC 157 Therapy Through the NO-System-Triple NO-Agent Approach in Rats
Madzarac G, Becejac T, Penovic T, et al.
Pharmaceuticals (Basel, Switzerland), 2026;19(1)